© 2022 BioMarin. All rights reserved.
Read about our latest treatment now approved in the U.S.
We are committed to the communities we treat beyond the therapies we develop.
Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address.